The Venture Codex Logo

The Venture Codex

ClavystBio

79 Science Park Drive, #04-05, Singapore, Central Singapore, 118264

Overview

Invests in early-stage biotech, medTech, and digital health ventures.

Founded

2021

Deals · 12mo

5

Links

WebsiteLinkedIn

Stage focus

Series A

Geographic focus

Singapore
The Netherlands
United States

Sector focus

—

Investment portfolio

14rounds
NAMEDATESIZE
Zenflow
Oct 2026Participated
$52 MSeries D
Cirrus Therapeutics
Aug 2026Led
$15 MSeed
Respiree
Jul 2026Led
$12 MSeries A
Leyden Labs
Jun 2026Participated
$45 MOther Equity
Rejoni
Jun 2026Participated
$25 MSeries C
Cirrus Therapeutics
Oct 2025Led
$11 MSeed
Allay Therapeutics
Jun 2025Led
$58 MSeries D
Nuevocor
May 2025Participated
$45 MSeries B
Callio Therapeutics
Mar 2025Participated
$187 MSeries A
Leyden Labs
Jan 2025Led
$70 MOther Equity
Sunbird Bio
Oct 2024Participated
$14 MOther Equity
NSG BioLabs
May 2024Participated
$15 MOther Equity
Zenflow
Oct 2026Participated
$52 MSeries D
Cirrus Therapeutics
Aug 2026Led
$15 MSeed
Respiree
Jul 2026Led
$12 MSeries A
Leyden Labs
Jun 2026Participated
$45 MOther Equity
Rejoni
Jun 2026Participated
$25 MSeries C
Cirrus Therapeutics
Oct 2025Led
$11 MSeed
Allay Therapeutics
Jun 2025Led
$58 MSeries D
Nuevocor
May 2025Participated
$45 MSeries B
Callio Therapeutics
Mar 2025Participated
$187 MSeries A
Leyden Labs
Jan 2025Led
$70 MOther Equity
Sunbird Bio
Oct 2024Participated
$14 MOther Equity
NSG BioLabs
May 2024Participated
$15 MOther Equity
14
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

ClavystBio: 14 funding rounds are recorded in the selected participation categories.All available history.
ClavystBio: 14 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed20
Series A22
Series B01
Series C+12
Other Equity13

Monthly Deal Activity

ClavystBio: 14 deals are recorded across 38 months.All available history.
ClavystBio: 14 deals are recorded across 38 months. All available history
MonthDeals
Sep '231
Oct '231
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '241
Jun '240
Jul '240
Aug '240
Sep '240
Oct '241
Nov '240
Dec '240
Jan '251
Feb '250
Mar '251
Apr '250
May '251
Jun '251
Jul '250
Aug '250
Sep '250
Oct '251
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '262
Jul '261
Aug '261
Sep '260
Oct '261

Sector Breakdown

ClavystBio: Health & Life Sciences is the largest displayed sector by deal count (14 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

ClavystBio: Health & Life Sciences is the largest displayed sector by deal count (14 deals). All available history
SectorDeals
Health & Life Sciences14
AI & Machine Learning2
Networks, Cloud & Communication1
Hardware & Robotics1
Fintech1
Real Estate & Construction1

Deal Size Distribution

ClavystBio: 14 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

ClavystBio: 14 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M6
$25M-$50M4
$50M-$100M3
$100M-$250M1
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

ClavystBio: United States has the largest recorded deal count among the displayed regions (7 deals).All available history.

Top 3 of 3 regions; European countries are grouped as Europe.

ClavystBio: United States has the largest recorded deal count among the displayed regions (7 deals). All available history
RegionDeals
United States7
Singapore5
Europe2
ClavystBio: 20 co-investors are shown, with EDBI sharing 6 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

ClavystBio: 20 co-investors are shown, with EDBI sharing 6 recorded deals. All available history
Co-investorShared deals
EDBI6
Polaris Partners5
SEEDS Capital5
Invus3
F-Prime Capital2
Accelerator Life Science Partners1
AMED Ventures1
Angelini Ventures1
Arboretum Ventures1
Ascension Ventures1
Bill & Melinda Gates Foundation1
Bluebird Ventures1
Boehringer Ingelheim1
Brandon Capital1
Byers Capital1
Casdin Capital1
Catalyst Health Ventures1
Cedars-Sinai Intellectual Property Co.1
Celadon Partners1
Cook Medical1

Investment Strategy

ClavystBio: Led accounts for 43% and participating for 57% of round participation.All available history.
ClavystBio: Led accounts for 43% and participating for 57% of round participation. All available history
CategoryDeals (count)Share (%)
Led643%
Participating857%
ClavystBio: Single-lead accounts for 33% and co-led for 67% of lead dynamics.All available history.
ClavystBio: Single-lead accounts for 33% and co-led for 67% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead233%
Co-led467%

Team

Sang Shin

Director, Digital Health